Global Infusion and Syringe Pump Market Size, Share, and COVID-19 Impact Analysis, By Type (Syringe Size 5 Ml, Syringe Size 10 Ml, Syringe Size 20 Ml, Syringe Size 30 Ml, Syringe Size 50 Ml, and Others), By Application (Hospitals, Home Care, Ambulatory Surgery Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Infusion and Syringe Pump Market Insights Forecasts to 2035

• Global Infusion and Syringe Pump Market Size is Expected To Grow from USD 20.2 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.2% from 2025 to 2035
• Global Infusion and Syringe Pump Market Size is Expected to Reach USD 38.75 Billion by 2035

The Global Infusion and Syringe Pump Market Size is Expected To Grow from USD 20.2 Billion in 2024 to USD 38.75 Billion by 2035, at a CAGR of 6.2% during the forecast period 2025-2035. Growing need for sophisticated drug delivery systems, growth in developing nations like China and India, the rise in chronic illness, and the expanding use of telemedicine and home healthcare solutions are all factors that present opportunities for the infusion and syringe pump market.

Market Overview

The global sector devoted to the creation, manufacturing, and distribution of medical devices intended for regulated medication delivery is known as the infusion and syringe pump market. While syringe pumps use a syringe mechanism for extremely precise, low-volume infusions, infusion pumps deliver fluids, such as nutrition and drugs, into a patient's body in precise amounts over predetermined durations. Critical care, oncology, pain management, and neonatal care all depend on these devices. Hospitals, clinics, and ambulatory surgery centers are served by its multiple divisions, which include volumetric, insulin, enteral, and ambulatory pumps.  

The aging of the world's population, the rise in chronic illness, and rising healthcare costs are all contributing to the infusion and syringe pump market. The sector is changing as a result of investments in digital health, gene therapy, and precision medicine, which are also lowering costs and increasing patient outcomes. Technological developments, the growing incidence of chronic illnesses, and the growing need for home healthcare solutions are the main factors propelling the infusion and syringe pump market.

Report Coverage

This research report categorizes the infusion and syringe pump market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the infusion and syringe pump market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the infusion and syringe pump market. 

Driving Factors

The market for infusion pumps and syringe pumps is also growing due to the rising demand for home healthcare services. The increasing prevalence of chronic illnesses like diabetes, cancer, and gastrointestinal disorders is one of the main factors propelling the infusion and syringe pump market. The market is expanding due to the rise in surgical operations as well as the rising acceptance of ambulatory care and home healthcare settings. The infusion and syringe pump market is expanding as a result of technological developments in the construction and operation of syringe and infusion pumps. The need for infusion therapies is also rising as a result of the world's aging population, particularly in situations including palliative and long-term care.

Restraining Factors

High equipment costs, complicated regulatory approvals, frequent product recalls resulting from software flaws, and the possibility of drug errors that jeopardize patient safety and impede market expansion are some of the restraining factors in the infusion and syringe pump market. 

Market Segmentation

The infusion and syringe pump market share is classified into type and application. 

• The syringe size 50 ml segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the type, the infusion and syringe pump market is divided into syringe size 5 ml, syringe size 10 ml, syringe size 20 ml, syringe size 30 ml, syringe size 50 ml, and others. Among these, the syringe size 50 ml segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. Rising healthcare demands, improvements in infusion system technology, and a growing desire for high-volume syringe pumps in both hospital and ambulatory care settings are the main factors driving the 50 ml syringe size. Its commercial dominance has been further strengthened by its adaptability for lengthy infusion operations and compatibility with a wide variety of medications.  

• The hospitals segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the infusion and syringe pump market is divided into hospitals, home care, ambulatory surgery centers, and others. Among these, the hospitals segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The increased incidence of chronic illnesses, the rise in surgical operations, and the expanding need for accurate and regulated medication delivery systems in clinical settings are the main factors driving the hospitals market. The growing use of automated medical technologies and the continuous expansion of healthcare infrastructure assist the hospitals segment.  

Regional Segment Analysis of the Infusion and Syringe Pump Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the infusion and syringe pump market over the predicted timeframe.

North America is anticipated to hold the largest share of the Infusion and Syringe Pump market over the predicted timeframe. The high incidence of chronic illnesses, a developed healthcare system, and the existence of significant market participants are propelling North America. Widespread use of customized infusion systems, advantageous reimbursement practices, and robust regulatory backing all assist the area.  The region's cutting-edge medical facilities, advantageous reimbursement practices, and growing uptake of cutting-edge medical technology are important drivers of market expansion. North America's sophisticated healthcare system, high rate of chronic illnesses, and growing elderly population.

Asia Pacific is expected to grow at a rapid CAGR in the infusion and syringe pump market during the forecast period. The Asia Pacific region's quick rise can be ascribed to greater awareness of innovative medical equipment, improved healthcare infrastructure, and rising healthcare expenditures. the Asia-Pacific area, which includes significant contributions from nations like China, India, and Japan. The need for infusion and syringe pumps in the area is also being driven by the region's aging population, rising chronic disease prevalence, and growing middle class, which has more disposable income.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the infusion and syringe pump market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Medima
• Becton
• Chemyx Inc
• KD Scientific
• Smiths Medical
• Braintree Scientific
• Terumo Corporation
• Baxter International Inc.
• Dickinson and Company
• B. Braun Melsungen AG
• Angel Electronic Equipment Co
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In July 2025, Penlon has announced the immediate launch of its new Infusion System range, featuring advanced infusion and syringe pumps. Designed to enhance clinical efficiency, safety, and precision, the Penlon HP TCi Syringe Pump offers reliable and accurate intravenous anaesthesia delivery, providing clinicians with improved control across diverse medical environments.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the infusion and syringe pump market based on the below-mentioned segments:  

Global Infusion and Syringe Pump Market, By Type

• Syringe Size 5 ml
• Syringe Size 10 ml
• Syringe Size 20 ml
• Syringe Size 30 ml
• Syringe Size 50 ml
• Others

Global Infusion and Syringe Pump Market, By Application

• Hospitals
• Home Care
• Ambulatory Surgery Centers
• Others

Global Infusion and Syringe Pump Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa